Please ensure Javascript is enabled for purposes of website accessibility Cir.No.164 of 2024 - Regarding SFDA Field Satety Corrective Action of Erytra Eflexis from (mir: Diagnostic Grifols, S.A). Cir.No.164 of 2024 - Regarding SFDA Field Satety Corrective Action of Erytra Eflexis from (mir: Diagnostic Grifols, S.A).
Alert :

Welcome to the beta version of the eHealth portal; our goal is to improve your experience by providing better eServices

Cir.No.164 of 2024 - Regarding SFDA Field Satety Corrective Action of Erytra Eflexis from (mir: Diagnostic Grifols, S.A).

Content Details
Medical devices and equipment department News and Safety Alerts
Cir.No.164 of 2024 - Regarding SFDA Field Satety Corrective Action of Erytra Eflexis from (mir: Diagnostic Grifols, S.A).
26/11/2024

Cir.No.164 of 2024 - Regarding SFDA Field Satety Corrective Action of Erytra Eflexis from (mir: Diagnostic Grifols, S.A).

View Download
3
Cir.No.164 of 2024 - Regarding SFDA Field Satety Corrective Action of Erytra Eflexis from (mir: Diagnostic Grifols, S.A).
Was this page helpful?
0 visitors liked this page of total 0 visitors
Be the first to evaluate this page

Add Reason (choose at least one)

الرجاء اختيار سببان كحد أعلى

هذا الحقل مطلوب

الرجاء كتابة نص صحيح

الملاحظات يجب ان تكون اقل من ٢٥٠ حرف

Share this page
Follow Us On